+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bionematicides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • TechSci Research
  • ID: 5636242
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Bionematicides Market is projected to expand from USD 414.62 Million in 2025 to USD 697.28 Million by 2031, reflecting a compound annual growth rate of 9.05%. These biological formulations, derived from natural sources like plant extracts and microorganisms, are engineered specifically to manage parasitic nematodes. The sector's growth is largely fueled by stricter regulations on synthetic chemical nematicides and a shift among food producers toward sustainable farming methods. This trend is corroborated by industry usage data; for instance, CropLife Brasil reported in 2024 that the average adoption rate of bionematicides by area reached 25 percent during the 2023 to 2024 harvest cycle.

However, market expansion faces a significant obstacle regarding field performance consistency compared to conventional chemical agents. Many biological solutions are highly sensitive to environmental factors such as soil moisture and temperature, often resulting in variable efficacy. This unpredictability creates hesitation among conventional farmers, who depend on the immediate and uniform results typically provided by synthetic inputs, thereby impeding broader adoption.

Market Drivers

Stringent regulatory measures phasing out synthetic chemical nematicides function as the primary driver transforming the global bionematicides market. As governments ban broad-spectrum agrochemicals to address environmental concerns, growers are compelled to switch to biological alternatives. A joint investigation report by Greenpeace and Public Eye in September 2025 highlighted this trend, noting that the number of pesticide chemicals banned in the European Union reached 75 in 2024, nearly doubling since 2018. This reduction in synthetic tools accelerates the adoption of biological solutions, a shift reflected in corporate performance; Corteva Agriscience reported a 7 percent increase in Crop Protection volume in their 'Third Quarter 2025 Results' (November 2025), attributing this growth to the rising demand for biologicals and new products.

Simultaneously, the rapid growth of global organic farming acreage creates a critical market for bionematicides, which are among the few inputs approved for organic production. As producers convert land to meet the demand for residue-free food, they rely on natural pest control to protect yields from nematodes without violating certification standards. According to 'The World of Organic Agriculture 2025' yearbook by FiBL and IFOAM - Organics International (February 2025), global organic farmland expanded by 2.5 million hectares in 2023, totaling nearly 99 million hectares. This growing acreage offers a guaranteed customer base for manufacturers, as organic growers depend exclusively on these formulations for effective pest management.

Market Challenges

The inconsistency of field performance compared to synthetic chemicals acts as a major hurdle to the Global Bionematicides Market. Unlike conventional agents that offer stable toxicity independent of external conditions, biological formulations typically contain living organisms that are susceptible to environmental fluctuations. Factors such as ultraviolet radiation, soil temperature, and moisture levels can degrade the viability of active ingredients, resulting in unreliable pest suppression. This unpredictability poses a substantial financial risk for agricultural producers operating on tight margins, as they require guaranteed protection to ensure harvest security.

Consequently, this reliability gap creates a barrier to market penetration, forcing many growers to use biologicals only as supplementary measures rather than standalone solutions. Data from CropLife Brasil in 2024 projected that the potential treated area with bio-inputs would reach 155.4 million hectares for the 2024 to 2025 harvest cycle. Although this indicates a massive operational footprint, the sector cannot fully capitalize on this potential due to hesitation regarding efficacy, preventing the complete substitution of chemical inputs. Widespread adoption as a primary control method will remain limited until biological consistency engenders a level of trust comparable to synthetic options.

Market Trends

The increasing use of seed treatment applications is transforming the delivery of bionematicides, especially for broad-acre crops where soil drenching poses logistical difficulties. Manufacturers are actively formulating biological active ingredients as seed coatings to provide immediate root zone protection during crucial germination stages, a method that integrates smoothly with large-scale corn and soybean operations. This transition toward low-labor, efficient delivery systems is driving product uptake in key regions; for instance, Corteva Agriscience reported a 16 percent increase in Crop Protection sales volume in their 'Fourth Quarter 2024 Results' (February 2025), explicitly linking this growth to the demand for new products, including biologicals, in the Latin American market.

Additionally, the commercialization of novel fungal and bacterial strains is improving market efficacy by introducing specific modes of action to combat resistant nematode populations. Innovation is focused on developing specialized microorganisms capable of actively parasitizing nematode eggs and juveniles, offering performance that rivals synthetic standards while adhering to strict environmental regulations. This trend is highlighted by recent regulatory achievements, such as Certis Biologicals securing the first EU authorization in the Netherlands for its new bionematicide, NemaClean, in March 2025. This product utilizes the proprietary Purpureocillium lilacinum strain PL11 to effectively control root-knot nematodes.

Key Players Profiled in the Bionematicides Market

  • Bayer CropScience AG
  • Beijing Ecoman Biotech Co., Ltd.
  • Certis USA LLC
  • Dow AgroSciences LLC
  • Marrone Bio Innovations, Inc.
  • Monsanto Company
  • Syngenta AG
  • Valent BioSciences Corporation
  • T. Stanes & Company Limited
  • Bio Huma Netics, Inc.

Report Scope

In this report, the Global Bionematicides Market has been segmented into the following categories:

Bionematicides Market, by Type:

  • Microbials
  • Biochemical

Bionematicides Market, by Form:

  • Liquid
  • Dry

Bionematicides Market, by Crop Type:

  • Cereals & Grains
  • Oilseeds & Pulses
  • Fruits & Vegetables
  • Others

Bionematicides Market, by Mode of Treatment:

  • Soil Treatment
  • Seed Treatment
  • Foliar Sprays
  • Others

Bionematicides Market, by Infestation:

  • Root Knot
  • Cyst Nematodes
  • Lesion Nematodes
  • Others

Bionematicides Market, by Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bionematicides Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Bionematicides Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Microbials, Biochemical)
5.2.2. By Form (Liquid, Dry)
5.2.3. By Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Others)
5.2.4. By Mode of Treatment (Soil Treatment, Seed Treatment, Foliar Sprays, Others)
5.2.5. By Infestation (Root Knot, Cyst Nematodes, Lesion Nematodes, Others)
5.2.6. By Region
5.2.7. By Company (2025)
5.3. Market Map
6. North America Bionematicides Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Form
6.2.3. By Crop Type
6.2.4. By Mode of Treatment
6.2.5. By Infestation
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Bionematicides Market Outlook
6.3.2. Canada Bionematicides Market Outlook
6.3.3. Mexico Bionematicides Market Outlook
7. Europe Bionematicides Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Form
7.2.3. By Crop Type
7.2.4. By Mode of Treatment
7.2.5. By Infestation
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Bionematicides Market Outlook
7.3.2. France Bionematicides Market Outlook
7.3.3. United Kingdom Bionematicides Market Outlook
7.3.4. Italy Bionematicides Market Outlook
7.3.5. Spain Bionematicides Market Outlook
8. Asia-Pacific Bionematicides Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Form
8.2.3. By Crop Type
8.2.4. By Mode of Treatment
8.2.5. By Infestation
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Bionematicides Market Outlook
8.3.2. India Bionematicides Market Outlook
8.3.3. Japan Bionematicides Market Outlook
8.3.4. South Korea Bionematicides Market Outlook
8.3.5. Australia Bionematicides Market Outlook
9. Middle East & Africa Bionematicides Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Form
9.2.3. By Crop Type
9.2.4. By Mode of Treatment
9.2.5. By Infestation
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Bionematicides Market Outlook
9.3.2. UAE Bionematicides Market Outlook
9.3.3. South Africa Bionematicides Market Outlook
10. South America Bionematicides Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Form
10.2.3. By Crop Type
10.2.4. By Mode of Treatment
10.2.5. By Infestation
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Bionematicides Market Outlook
10.3.2. Colombia Bionematicides Market Outlook
10.3.3. Argentina Bionematicides Market Outlook
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Mergers & Acquisitions (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Bionematicides Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Bayer CropScience AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Beijing Ecoman Biotech Co., Ltd.
15.3. Certis USA LLC
15.4. Dow AgroSciences LLC
15.5. Marrone Bio Innovations, Inc.
15.6. Monsanto Company
15.7. Syngenta AG
15.8. Valent BioSciences Corporation
15.9. T. Stanes & Company Limited
15.10. Bio Huma Netics, Inc.
16. Strategic Recommendations

Companies Mentioned

The key players profiled in this Bionematicides market report include:
  • Bayer CropScience AG
  • Beijing Ecoman Biotech Co., Ltd.
  • Certis USA LLC
  • Dow AgroSciences LLC
  • Marrone Bio Innovations, Inc.
  • Monsanto Company
  • Syngenta AG
  • Valent BioSciences Corporation
  • T. Stanes & Company Limited
  • Bio Huma Netics, Inc.

Table Information